• Sign In
  • My Marketwire Account
  • Marketwire Resonate
  • News Dashboard 2.0
  • Mediahub
  • Personal Beat
  • Hot Off the Wire
• Register
• Français
• Marketwired Blog
• Careers
• Contact Marketwired

Browse By:

• Industry
  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals
  • Computers and Software
  • Education and Training
  • Electronics and Semiconductors
  • Energy and Utilities
  • Environment
  • Financial Services
  • Food and Beverage
  • Government
  • Lifestyle and Leisure
  • Manufacturing and Production
  • Media and Entertainment
  • Medical and Healthcare
  • Pharmaceuticals and Biotech
  • Professional Services
  • Real Estate and Construction
  • Retail
  • Sports
  • Telecom
  • Transportation and Logistics
  • Travel and Hospitality
• Topic
  • Associations
  • Bankruptcy
  • Class action
  • Conference calls
  • Dividends
  • Earnings
  • Earnings projections
  • Financing agreements
  • Initial public offerings
  • Investment opinion
  • Management changes
  • Media advisory
  • Mergers and acquisitions
  • Special news events
  • Stock splits
  • Stock/other market news
  • Trade shows
  • Webcasts
• Type
  • News Releases
  • Media Advisories
  • Feature Packs
  • Webcasts
  • Social Media 2.0

News Room: Biotech

Lorus Therapeutics Closes Private Placement
TORONTO, ONTARIO--(Marketwired - June 19, 2013) - NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Lorus Therapeutics Inc. (TSX...(more)
LORUS THERAPEUTICS INC.  
Jun 19, 2013 17:35 ET
 

 

Avita Medical Analyst Coverage Initiated by Zacks
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 19, 2013) - Regenerative medicine Company Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) is pleased to announce that Zacks...(more)
Avita Medical  
Jun 19, 2013 16:36 ET
 

 

La FDA accorde à Paladin le statut d'évaluation prioritaire relativement à sa demande d'homologation d'un nouveau médicament pour Impavido(R)
MONTRÉAL, CANADA--(Marketwired - 19 juin 2013) - La société Laboratoires Paladin inc. (« Paladin ») (TSX:PLB) a annoncé aujourd'hui qu'elle avait été informée du fait que sa demande d...(more)
Laboratoires Paladin Inc.  
Jun 19, 2013 16:30 ET
 

 

Paladin Receives Priority Review Status from FDA for Impavido(R) NDA Submission
MONTREAL, CANADA--(Marketwired - June 19, 2013) - Paladin Labs Inc. ("Paladin")(TSX:PLB) announced today that it has received notice that its new drug application (NDA) to the U.S...(more)
Paladin Labs Inc.  
Jun 19, 2013 16:30 ET
 

 

Patentes de pruebas FLT3 de Invivoscribe fortalecidas por dictamen de la Corte Suprema
SAN DIEGO, CA--(Marketwired - Jun 19, 2013) - En el asunto de Association of Molecular Pathology c. Myriad, la Corte Suprema de los Estados Unidos rechazó las reclamaciones de patentes de genes...(more)
Invivoscribe Technologies, Inc.  
Jun 19, 2013 14:09 ET
 

 

MD MessageTRAC: A New Competitive Edge for Life Science Companies
TOTOWA, NJ--(Marketwired - Jun 19, 2013) - The Dunn Group, Inc., a leading business and competitive intelligence (BI/CI) firm dedicated to the life sciences industry, today announced the launch...(more)
The Dunn Group  
Jun 19, 2013 13:34 ET
 

 

Large Pharma Show They Are "Quackers4Quanticate" by Awarding Large Programs of Work Leading to Expansion of U.S. Presence
BOSTON, MA and RESEARCH TRIANGLE PARK, NC--(Marketwired - Jun 19, 2013) - Quanticate, a leading global data-focused clinical research organization (CRO) today announced the relocation of its U.S...(more)
Quanticate  
Jun 19, 2013 12:30 ET
 

 

Prana Presents New Benchmark Test to Assess Huntington's Disease Patients in Clinical Trials
MELBOURNE, AUSTRALIA--(Marketwired - Jun 19, 2013) - Melbourne-based Prana Biotechnology (ASX: PBT) (NASDAQ: PRAN) has unveiled a world first, patient-reported outcomes study for Huntington's...(more)
Prana Biotechnology  
Jun 19, 2013 09:19 ET
 

 

Dynavax Chief Scientific Officer Awarded Prestigious Immunology Prize
BERKELEY, CA--(Marketwired - Jun 19, 2013) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that the 2013 Novartis Prize for Basic Immunology has been awarded to Dr. Robert L...(more)
Dynavax Technologies  
Jun 19, 2013 09:00 ET
 

 

Invivoscribe FLT3 Testing Patents Strengthened by Supreme Court Ruling
SAN DIEGO, CA--(Marketwired - Jun 19, 2013) -  In Association of Molecular Pathology v. Myriad, the U.S. Supreme Court struck down BRCA1 and BRCA2 gene patent claims. It is important for the...(more)
Invivoscribe Technologies, Inc.  
Jun 19, 2013 08:36 ET